Clinical Trial

Forced Oscillations Technique During a Metacholine Test in Children

Study acronym: TPM AOS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 13, 2023 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Asthma is the most common chronic lung disease in children. It affects more than 1 in 10 children in France. The methacholine bronchial challenge test (MBT) is indicated to assess the probability of asthma suggested by clinical symptoms by measuring the forced expiratory volume in one second (FEV1), after inhalation of a cumulative dose of methacholine. In children, the measurement of FEV1 requires a high level of cooperation from the child, which can be the source of false negatives or no result if this is not obtained. The objective of this study is to evaluate if the measurement of the respiratory function by the forced oscillations technique, allows to predict the variation of the FEV1 obtained
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-02-15; most recent amendment 2023-09-12.
Status change: Not Yet Recruiting → Recruiting 2023-09-12
Trial Details
NCT Number NCT05734261
Lead Sponsor University Hospital, Montpellier
Conditions Asthma in Children
Enrollment 112 participants
Start Date 2023-09-07
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2023-09-13